Cell and gene therapy at BIO 2027
Jun 7–10, 2027 Philadelphia, PA ~22k attendees Website
15 organizations at BIO 2027 present work in cell and gene therapy: 14 contract manufacturers, research organizations and suppliers and 1 pharma or biotech company. 15 of them have their own page in this guide. As of Sep 27, 2026.
Showing 1–15 of 15 organizations
| Organization | BIO 2027 Attendance |
|---|---|
AGC Biologics Bothell, WA | |
Global CDMO developing and manufacturing protein biologics, plasmid DNA, mRNA, viral vectors and engineered cell therapies. | Booth Exhibiting at Booth 137 |
Biomay Vienna, Austria | |
Austrian contract manufacturer producing plasmid DNA, mRNA and recombinant proteins under GMP, from gene design to market supply. | Booth Exhibiting at Booth 416 |
Catalent Somerset, NJ | |
Global CDMO developing and manufacturing medicines, biologics, gene therapies and consumer health products for pharma and biotech companies. | Booth Exhibiting at Booth 337 |
Cellipont Bioservices The Woodlands, TX | |
Cell therapy CDMO offering process development, analytics and cGMP manufacturing at a new facility in The Woodlands, Texas. | Booth Exhibiting at Booth 429 |
eXmoor Pharma Bristol, UK | |
UK cell and gene therapy CDMO that pairs CMC consulting with process development and GMP manufacturing. | Booth Exhibiting at Booth 401 |
IDT Biologika Dessau-Rosslau, Germany | |
German CDMO, part of SK bioscience, making viral vaccines, gene and immune therapies, antibodies and sterile fill-finish products. | Booth Exhibiting at Booth 2039 |
Leman Biotech Shenzhen, China | |
Chinese CAR-T developer whose metabolically enhanced CD19 CAR-T therapy has been cleared for clinical trials in China. | Booth Exhibiting at Booth 403 |
Minaris Philadelphia, PA | |
Cell and gene therapy CDMO that also runs biosafety testing for biologics, antibodies, vaccines and advanced therapies. | Booth Exhibiting at Booth 1261 |
NewBiologix Epalinges, Switzerland | |
Swiss company offering engineered producer cell lines and other technologies to make AAV gene therapies more cheaply. | Booth Exhibiting at Booth 2219 |
OXB Oxford, UK | |
UK cell and gene therapy CDMO, formerly Oxford Biomedica, developing and manufacturing lentiviral, AAV and other viral vectors. | Booth Exhibiting at Booth 415 |
PackGene Houston, TX | |
Cell and gene therapy CRO and CDMO making AAV and lentiviral vectors, plasmid DNA and mRNA, from research grade to GMP. | Booth Exhibiting at Booth 712 |
ProBioGen Berlin, Germany | |
German CDMO and technology provider that engineers cell lines, develops processes and manufactures proteins, viral vectors and vaccines under GMP. | Booth Exhibiting at Booth 218 |
Resilience Blue Ash, OH | |
North American biomanufacturing CDMO for biologics, drug product and cell therapies. | Booth Exhibiting at Booth 331 |
ST Pharm Seoul, South Korea | |
Korean CDMO manufacturing oligonucleotides and mRNA for nucleic-acid and gene therapies. | Booth Exhibiting at Booth 2335 |
Symbiosis Pharmaceutical Services Stirling, UK | |
Scottish sterile manufacturing CDMO offering fill-finish of vaccines, antibodies and viral vectors at clinical and small commercial scale. | Booth Exhibiting at Booth 500 |
Instantly find 20 buyers in cell and gene therapy
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse BIO 2027 by
Organization type
Offers
Exhibit hall
Everyone
Not affiliated with the Biotechnology Innovation Organization or the BIO International Convention. Organization details are derived from BIO’s published exhibitor list and each exhibitor’s own website. Submit a correction